Revenue and EBIT increased again in 2024, despite a volatile environmentNumber of core employees grew furtherDEKRA is very well positioned in its 100th anniversary year as it successfully transforms from a traditional vehicle inspection provider into a leading independent expert for digital and software-defined mobility

STUTTGART, Germany, April 14, 2025 /PRNewswire/ — DEKRA remained on track in 2024, again growing its business in a volatile economic and geopolitical environment. Global revenues increased by 4.7% to 4.29 billion euros, rising by 7% in the core business—excluding temporary work. EBIT improved by 4.2% to 266 million euros, while EBITDA rose by 5.4% to 480.1 million euros. Moreover, DEKRA’s core workforce grew by 800 employees to around 33,000. In total, some 48,000 experts work for the world’s leading non-listed testing, inspection, and certification organization.

“Thanks to our future-oriented business model, we were able to ensure robust revenue and earnings growth in another year of substantial economic tensions. The decision to focus on the key megatrends of Future Mobility, Sustainability, Cybersecurity, and Artificial Intelligence with our ‘Strategy 2025’ was essential to our economic success in 2024,” said DEKRA CEO Stan Zurkiewicz at the company’s Annual Press Conference at its headquarters in Stuttgart, Germany.

“Our people are our greatest asset. That is why we are proud to have continued expanding DEKRA’s core employee base in turbulent times like these,” added DEKRA CFO and Human Resources director Wolfgang Linsenmaier. “This is strong testimony to the resilience of DEKRA’s business model and our clear-cut ambitions going forward.”

Read the full version here:  https://www.dekra.in/en/dekra-continues-on-a-path-of-growth-and-transformation/

About DEKRA
For 100 years, DEKRA has been a trusted name in safety. Founded in 1925 with the original goal of improving road safety through vehicle inspections, DEKRA has grown to become the world’s largest independent, non-listed expert organization in the field of testing, inspection, and certification. Today, as a global partner, the company supports its customers with comprehensive services and solutions to drive safety and sustainability forward—fully aligned with DEKRA’s anniversary motto, “Securing the Future.” In 2024, DEKRA generated revenue of 4.3 billion euros. Around 48,000 employees are providing qualified and independent expert services in approximately 60 countries across five continents. DEKRA holds a Platinum rating from EcoVadis, placing it among the top 1% of the world’s most sustainable companies.

Logo – https://mma.prnewswire.com/media/2399413/DEKRA_logo_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/future-oriented-business-model-ensures-successful-fiscal-year-2024-dekra-continues-on-a-path-of-growth-and-transformation-302427295.html

HONG KONG, April 14, 2025 /PRNewswire/ — Lingnan University has achieved a historic milestone at the 50th International Exhibition of Inventions Geneva, winning a record-breaking number of five awards. A total of six groundbreaking inventions from Lingnan were showcased at the exhibition, earning one Gold Medal with Congratulations of the Jury―the first time the University has achieved this honour―along with two Silver Medals and two Bronze Medals, making the number of Lingnan University’s participating and winning projects a record high.

Prof S. Joe Qin, President and Wai Kee Kau Chair Professor of Data Science, conveyed his appreciation for the record-breaking achievements of Lingnan University. He said, “This year, Lingnan has achieved a historic milestone with the number of innovative inventions showcased and awarded at the exhibition. This exceptional accomplishment reflects the University’s international recognition in the fields of science, innovation and technology transfer, further strengthening its position as a pivotal player in the global innovation arena. Lingnan will continue to focus on nurturing well-rounded liberal arts and sciences talents, advancing ‘human-centred’ AI research and development, promoting high-quality research, and enhancing ‘industry-academia-research’ collaboration. These initiatives will accelerate the transformation of research outcomes into impactful innovations, fostering the development of new quality productive forces and establishing Lingnan as a leading comprehensive university in arts and sciences in the digital era.”

For the first time, Lingnan presented multiple inventions from various faculties and departments, showcasing its collaborative spirit and ingenuity. The six groundbreaking inventions exhibited in the exhibition covered areas such as intelligent transport, digital security, carbon neutral technology and humanitarian technology, which fully demonstrated Lingnan’s strength in innovation and scientific research and its contribution to the community.

“BLOOM – A Low-cost, Energy-efficient Baby Incubator Designed for Remote and Rural Communities in Developing Countries”, which was developed by a team led by Prof Albert Ko, Director of Office of Service-Learning and Lingnan Entrepreneurship Initiative (LEI), has been awarded the Gold Medal with Congratulations of the Jury.

Silver Award-winning projects include “A Multi-time-scale Model for Day-ahead Forecasting of Passenger Travel-time and Destinations Distribution” led by President S. Joe Qin; and “Direct Air Capture Robot (DACR) System Based on Mobile Automatic Cruise Tracking Coupled with Solar Photovoltaic Power Generation and Waste Heat Recovery System” led by Prof Li Jia, Associate Professor of School of Interdisciplinary Studies.

Bronze Award-winning projects include “Decentralised Authentication of Anti-Counterfeiting QR Codes Using Vision Transformer-Based Federated Learning” led by Prof Prof Sam Kwong Tak-wu, Associate Vice-President (Strategic Research) ), Acting Dean of the School of Data Science, Dean of the School of Graduate Studies and J.K. Lee Chair Professor of Computational Intelligence; and “EmergentSync: An Intelligent Traffic Light System with Emergency Response” led by Prof Pan Fei, Assistant Professor of School of Interdisciplinary Studies.

Prof Sam Kwong Tak-wu, led the research project on “Decentralised Authentication of Anti-Counterfeiting QR Codes Using Vision Transformer-Based Federated Learning”, which won the Bronze Medal, is delighted by this remarkable achievement and said, “This award is full recognition of our team’s pioneering research and demonstrates Lingnan University’s strong commitment to cultivating young talent and transforming research outcomes into practical applications. We aim to continue addressing the urgent challenges facing the world today through innovative inventions. Moving forward, we will deepen our efforts in the relevant fields and actively expand our networks with the government and industry, and leverage our research capabilities to make greater contributions to society.”

The International Exhibition of Inventions Geneva is one of the world’s most important annual events in the field of invention, this year showcasing more than 1,050 inventions from around 35 countries or regions.

List of awarded projects and introduction

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/lingnan-university-shines-at-international-exhibition-of-inventions-geneva-winning-5-prizes–record-breaking-number-of-exhibitors-and-awards-winning-achievements-302427298.html

SOURCE Lingnan University

SHENZHEN, China, April 13, 2025 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, proudly marks a decade since the commercialization of its proprietary DNBSEQ™ sequencing technology. Over the past ten years, DNBSEQ™ has transformed the landscape of genomics by delivering high-performance, cost-effective sequencing solutions that empower scientists, clinicians, and innovators across the globe.

First commercial launched in 2015, DNBSEQ™ has become a trusted platform for cutting-edge research and diagnostics—spanning over 3,900 installations worldwide and contributing to more than 10,900 peer-reviewed publications*. Today, DNBSEQ™ continues to stand at the forefront of sequencing innovation, driving progress in precision medicine, public health, agriculture, biodiversity, and more.

A Decade of Speed and Scale in Innovation

Powered by proprietary DNA nanoball (DNB) technology and patterned arrays, DNBSEQ™ delivers exceptional accuracy, lower duplication rates, and minimal index hopping—resulting in high-quality data at significantly lower cost. These advantages make it an ideal choice for both large-scale studies and sensitive clinical applications.DNBSEQä technology has been widely praised by users for its outstanding data quality and cost-effectiveness in different applications, including whole-genome sequencing (WGS) and whole-exome sequencing (WES). Research has also identified the platform as an excellent candidate for eukaryotic genome sequencing, metagenomic sequencing, bacterial genome research, and more, demonstrating its versatility and reliability across scenarios.

DNBSEQ™ has redefined the speed of innovation in genomic technology, offering the widest range of sequencing throughput and application coverage in the industry. Today, MGI offers a comprehensive portfolio of genetic sequencers based on DNBSEQä under T, G, and E series, including the ultra-high-throughput DNBSEQ-T20×2 which delivered the world’s first sub-$100 human genome; the widely adopted DNBSEQ-T7 for high-throughput versatility; the ultra-compact DNBSEQ-E25 designed for fieldwork and decentralized testing; the benchtop DNBSEQ-G400;and the fastest in its class for mid-to-low throughput sequencing DNBSEQ-G99; MGI’s newest flagship, the DNBSEQ-T1+, represents the latest evolution of this journey—an ultra-fast benchtop sequencer that balances power, speed, and flexibility. It reflects MGI’s ongoing commitment to continuous innovation, empowering researchers to accelerate discovery without compromise.

Enabling Multi-Omics and Real-World Impact

More than a sequencing platform, DNBSEQ™ enables a wide range of multi-omics applications—including genomics, transcriptomics, epigenomics, single-cell, and spatial omics. These capabilities make it a powerful tool across diverse scientific fields, enabling deeper insights into disease mechanisms, environmental interactions, and biological systems.

Proven in extreme environments—from the depths of the Mariana Trench to the peak of Mount Everest—DNBSEQ™ continues to deliver high-quality, reliable results wherever science needs to go.

End-to-End Solutions: Making Science Simpler

MGI complements its sequencing platforms with a suite of automation and BIT tools that deliver a seamless end-to-end workflow—from sample preparation to data analysis. These integrated solutions improve efficiency, reduce manual effort, and bring advanced genomic tools within reach for more users, regardless of lab size or location.

Inspired by the question “What if science had no barriers?”, MGI’s technology ecosystem is designed to remove bottlenecks and lower costs, enabling researchers to focus on discovery—not complexity.

Toward the $10 Genome and a More Equitable Future

As MGI looks to the future, the company is focused on achieving its most ambitious goal yet: the $10 genome. Building on the foundation of DNBSEQ™, MGI is developing next-generation sequencing technologies to further reduce costs, increase accessibility, and accelerate time to insight.

“Over the past decade, DNBSEQ™ has grown from an innovation into a global standard for high-quality, affordable sequencing,” said Dr. Rade Drmanac, Chief Scientific Officer at MGI. “We’ve opened doors for researchers everywhere—and now, we’re building the next chapter in accessible genomics.”

Genomics for All: The Mission Continues

Celebrating 10 years of DNBSEQ™ is more than a technological milestone—it is a reaffirmation of MGI’s mission: to make genomics accessible, affordable, and impactful for all. By delivering the tools that drive discovery, MGI is helping to build a healthier, more informed, and more connected world—one genome at a time.

For more information on DNBSEQ™ technology and MGI’s full product portfolio, visit: https://en.mgi-tech.com

* statistics as of 30 Jun 2024

About MGI 

MGI Tech Co., Ltd.  (or its subsidiaries, together referred to MGI), is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and have established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. To learn more, please visit https://en.mgi-tech.com/ , Linkedin, X, and Youtube.  

View original content to download multimedia:https://www.prnewswire.com/news-releases/mgi-tech-celebrates-10-years-of-dnbseq-technology-driving-genomics-forward-with-speed-scale-and-accessibility-302427245.html

SOURCE MGI TECH